TY - JOUR
T1 - High peak estradiol/mature oocyte ratio predicts lower clinical pregnancy, ongoing pregnancy, and live birth rates in GnRH antagonist intracytoplasmic sperm injection cycles
AU - Sandoval, Juan S.
AU - Steward, Ryan G.
AU - Chen, Chen
AU - Li, Yi Ju
AU - Price, Thomas M.
AU - Muasher, Suheil J.
N1 - Publisher Copyright:
© Journal of Reproductive Medicine®, Inc.
PY - 2016/2
Y1 - 2016/2
N2 - OBJECTIVE: To define the relationship between peak estradiol (E2)/mature oocyte ratio and pregnancy outcomes in gonadotropin-releasing hormone (GnRH) antagonist intracytoplasmic sperm injection (ICSI) cycles. STUDY DESIGN: Retrospective cohort study in the setting of an academic re-productive medicine practice. Records from 162 fresh, autologous, GnRH antagonist ICSI cycles performed between 2009 and 2012 were analyzed. The main outcome measures were rates of clinical pregnancy (CPR), ongoing pregnancy (OPR), and live birth (LBR). RESULTS: For the primary analysis, 4 groups were created based on peak E2/mature oocyte ratio (group 1: <200, group 2: 200–300, group 3: 300–400, and group 4: >400 pg/mL/oocyte). After adjusting for age, basal FSH, and the number of mature oocytes, a significantly lower OPR was seen in group 4 as compared to group 1 (OR 0.15, 95% CI 0.03–0.86; p=0.032) and group 3 (OR 0.17, 95% CI 0.03–0.98; p=0.048), respectively. The adjusted LBR was also significantly lower in group 4 as compared to group 1 (OR 0.15, 95% CI 0.03–0.83; p=0.030). In a secondary analysis, 3 ranges of peak E2/ mature oocyte ratio (<200, 200–400, and >400 pg/ mL/oocyte) were compared between low, normal, and high responders (<6, 6–15, and >15 mature oocytes, respectively). Clinical pregnancy rate, OPR, and LBR were all lower in normal responders when the E2/oocyte ratio exceeded 400 pg/mL/oocyte as compared to <200 pg/mL/oocyte and 200–300 pg/mL/oocyte (CPR 1% vs. 16% and 32%, respectively, p=0.017; OPR 0 vs. 15% and 27%, respectively, p=0.011; and LBR 0 vs. 13% and 26%, respectively, p=0.018). CONCLUSION: Very elevated peak E2/mature oocyte ratio is associated with a lower CPR, OPR, and LBR in fresh, autologous, GnRH antagonist ICSI cycles.
AB - OBJECTIVE: To define the relationship between peak estradiol (E2)/mature oocyte ratio and pregnancy outcomes in gonadotropin-releasing hormone (GnRH) antagonist intracytoplasmic sperm injection (ICSI) cycles. STUDY DESIGN: Retrospective cohort study in the setting of an academic re-productive medicine practice. Records from 162 fresh, autologous, GnRH antagonist ICSI cycles performed between 2009 and 2012 were analyzed. The main outcome measures were rates of clinical pregnancy (CPR), ongoing pregnancy (OPR), and live birth (LBR). RESULTS: For the primary analysis, 4 groups were created based on peak E2/mature oocyte ratio (group 1: <200, group 2: 200–300, group 3: 300–400, and group 4: >400 pg/mL/oocyte). After adjusting for age, basal FSH, and the number of mature oocytes, a significantly lower OPR was seen in group 4 as compared to group 1 (OR 0.15, 95% CI 0.03–0.86; p=0.032) and group 3 (OR 0.17, 95% CI 0.03–0.98; p=0.048), respectively. The adjusted LBR was also significantly lower in group 4 as compared to group 1 (OR 0.15, 95% CI 0.03–0.83; p=0.030). In a secondary analysis, 3 ranges of peak E2/ mature oocyte ratio (<200, 200–400, and >400 pg/ mL/oocyte) were compared between low, normal, and high responders (<6, 6–15, and >15 mature oocytes, respectively). Clinical pregnancy rate, OPR, and LBR were all lower in normal responders when the E2/oocyte ratio exceeded 400 pg/mL/oocyte as compared to <200 pg/mL/oocyte and 200–300 pg/mL/oocyte (CPR 1% vs. 16% and 32%, respectively, p=0.017; OPR 0 vs. 15% and 27%, respectively, p=0.011; and LBR 0 vs. 13% and 26%, respectively, p=0.018). CONCLUSION: Very elevated peak E2/mature oocyte ratio is associated with a lower CPR, OPR, and LBR in fresh, autologous, GnRH antagonist ICSI cycles.
KW - GnRH
KW - GnRH antagonist
KW - Gonadotropin-releasing hormone
KW - ICSI
KW - In vitro fertilization
KW - Intracytoplasmic sperm injections
KW - Live birth rate
KW - Live-birth pregnancy rate
KW - Pregnancy rate
UR - http://www.scopus.com/inward/record.url?scp=84957680537&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957680537&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84957680537
SN - 0024-7758
VL - 61
SP - 11
EP - 16
JO - Journal of Reproductive Medicine
JF - Journal of Reproductive Medicine
IS - 1
ER -